Now Available! | Check out UMR’s 2025 Annual Economic Report and State Toolkits today

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Pandemic leads to broader use of monoclonal antibodies

Most at risk: the millions of Americans who are still unvaccinated or not fully vaccinated, and those whose immune systems are compromised or have been suppressed and do not respond to vaccinations. These include patients being treated for cancer or who have received organ transplants.

That is why antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered by James Crowe Jr., MD, Robert Carnahan, PhD, and colleagues at Vanderbilt University Medical Center, are so important in the continuing fight against COVID-19.